Has the time come to shorten TB treatment and TB preventive therapy?

C. Magis-Escurra (Nijmegen, Netherlands)

Source: Virtual Congress 2021 – Respiratory infections
Session: Respiratory infections
Session type: State of the art session
Number: 1234

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Magis-Escurra (Nijmegen, Netherlands). Has the time come to shorten TB treatment and TB preventive therapy?. Virtual Congress 2021 – Respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
On abandon of the tuberculosis treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 522s
Year: 2003

Early experience with the implementation of the WHO shorter MDR-TB treatment regimen in Singapore
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018

Do we need to screen for latent TB when initiating a methotrexate treatment?
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 589s
Year: 2006

A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Experience of isofon use for therapy and chemoprophylaxis of tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 486s
Year: 2004

Should we treat every patient with latent TB? Is there a cost to pay?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018

How did the tuberculosis patients reach to a tuberculosis dispensary and how long did it take?
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011

Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014

Choice and adherence in preventive treatment for tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003

Is DOTS-Plus effective and cost-effective?
Source: Annual Congress 2007 - PG18 - New challenges in fighting tuberculosis in Europe
Year: 2007

Directly observed therapy versus self administered therapy for patients of new smear positive pulmonary tuberculosis during hospitalisation period
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Do empiric antibiotics delay appropriate antituberculosis medication in patients with active pulmonary tuberculosis?
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008

A choice of regimen improves completion for patients with latent TB infection
Source: Breathe 2008; 4: 366
Year: 2008

The effectiveness of the treatment of patients with TB in the condition adapted DOTS-strategy in Ukraine
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008

How soon does tuberculosis in HIV infected patients respond to anti-tuberculous treatment?
Source: Annual Congress 2010 - Tuberculosis and HIV coinfection
Year: 2010

Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008

Long term treatment out come in multi drug resistant tuberculosis
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010